Fundraising FoxMirae Asset Venture Investment — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupAbbVie+3 more
Dalpha builds AI technology, including a system it calls the Cobra World Model, focused on predicting human behavior to generate insights.
AI & Machine LearningEnterprise Software
Yoo Seon-bin(Co-Founder)Kim Do-gyun(CEO)
Co-investorsDunamu & PartnersSazzeSpringCampDSC InvestmentIMM InvestmentIntervest+1 more
Datarize offers an AI-powered product recommendation widget for online stores that analyzes each shopper's recent views, cart contents, and purchase history to automatically surface the items they are most likely to buy.
AI & Machine LearningE-commerceMarketing TechSeoul, KR
Gyumin Lee(Co-Founder & CISO)inSeongmoo Kim(Founder)inMinseong Park(Co-Founder & CSO)
Co-investorsAtinum Investment Co. Ltd.Naver D2SFWe VenturesStonebridge Ventures
Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.
HealthtechMedical DevicesRoboticsMiami, US
Alon Mozes(Founder)inJuan Salcedo(Founder)inDennis Moses(Chief Technical Officer)inAndres Carrillo(VP of Product)inJorge Fernandes(VP of Quality & Regulatory)inGabe Goldberg(VP of Marketing)in
Co-investorsIntuitive VenturesNorwest Venture PartnersVivo CapitalCLI VenturesFlorida Opportunity FundMithril Capital Management+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.